Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Curr Opin Cell Biol. 2008 Apr 3;20(2):126–136. doi: 10.1016/j.ceb.2008.02.005

Table 1.

FoxO target genes and functions

Cellular output Gene Function Regulation in cells Binding to promoter Regulation of promoter References
Metabolism G6pc glycogenolysis + EMSA + [19,29,57]
Igfbp1 regulates IGF activity + ChIP + [27,57,58,59]
Ppargc1 α gluconeogenesis + [57]
Pck1 gluconeogenesis + EMSA + [57,58]
Food intake Agrp orexigenic neuropeptide + ChIP; EMSA + [61,62]
Npy orexigenic neuropeptide + ChIP; EMSA + [61]
Pomc anorexigenic neuropeptide - ChIP; EMSA + [61,62]
Atrophy Atrogin-1/MAFbx muscle-specific ubiquitin ligase + EMSA + [66,67]
MuRF1 muscle-specific ubiquitin ligase + [66]
Autophagy Bnip3 Bcl2-related autophagy regulator + ChIP [21,70]
Gabarapl1 autophagosome formation + ChIP [72]
LC3 autophagosome formation + ChIP + [70,72]
Atg12I autophagy-related gene + ChIP [72]
Apoptosis Bim Bcl2-interacting mediator of cell death + ChIP + [15,28,75]
hid pro-apoptotic + ChIP [76]
Fas ligand pro-apoptotic tumor necrosis factor ligand + [1]
Cell cycle arrest p27Kip1 binds to and inhibits the cyclin E–CDK2 complex + + [18,82]
p21Cip1 binds to and inhibits the cyclin E–CDK2 complex + ChIP + [30,34]
p19INK4d p19Arf binds to and inhibits cyclin D–CDK4/6 complexes + ChIP; EMSA + [32,83]
p15INK4b binds to and inhibits cyclin D–CDK4/6 complexes + ChIP; EMSA + [32,33,34]
Angiogenesis Sprouty2 inhibitor of tyrosine kinase signaling + ChIP [63]
eNOS endothelial function and neovascularization - ChIP + [64]
Ang2 vascular remodelling factor + [64]
Cited2 CBP/p300-interacting transactivator + ChIP + [38,63]
Stress resistance MnSOD manganese superoxide dismutase + ChIP + [20,82]
Gadd45α growth arrest- and DNA damage-inducible gene 45 α + + [21]

Footnotes

The list of target genes is not exhaustive.

Regulation in cells details whether FoxO factors promote (+) or suppress (-) target gene expression in cultured cells by assessment of mRNA or protein levels.

Direct binding of FoxO factors to the promoter was assessed by chromatin immunoprecipitation (ChIP) or electromobility shift assay (EMSA).

Regulation of promoters was tested by the ability of FoxO factors to specifically drive luciferase expression.